Syndecan-1 could be added to hormonal receptors and HER2/neu in routine assessment of invasive breast carcinoma, relation of its expression to prognosis and clinicopathological parameters-Reference-Cited by-同舟云学术

Syndecan-1 could be added to hormonal receptors and HER2/neu in routine assessment of invasive breast carcinoma, relation of its expression to prognosis and clinicopathological parameters

Published:2019-05 Issue:5 Volume:215 Page:977-982
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Soliman Nahed A.,Yussif Shaimaa M.,Shebl Abdelhadi M.

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference31 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;A.W;J. Clin. Oncol.,2006

2. Modelling breast cancer: one size does not fit all;Vargo-Gogola;Nat. Rev. Cancer,2007

3. Rosen’s breast pathology;Rosen,2001

4. Invasive lobular carcinoma;FA,1999

5. Molecular subtyping of breast cancer: opportunities for new therapeutic approaches;M.R;Cell. Mol. Life Sci.,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of hormone receptors and human epidermal growth Factor2/Neu in female breast cancer patients;Kuwait Journal of Science;2024-10

2. Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer;PLOS ONE;2024-04-18

3. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling;Biochimie;2023-04

4. Bioinformatics Analysis of the Potentially Functional circRNA-miRNA-mRNA Network in Breast Cancer;2022-01-11

5. Glycosylation and its implications in breast cancer;Expert Review of Proteomics;2019-07-25